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Differentiation of memory cells involves DNA-se-
quence changes in B lymphocytes but is less clearly
defined in T cells. RNA rearrangement is identified
here as a key event in memory T cell differentiation
by analysis of a mouse mutation that altered the pro-
portions of naive and memory T cells and crippled
the process of Ptprc exon silencing needed to gener-
ate CD45RO in memory T cells. A single substitution
in amemory-induced RNA-binding protein, hnRNPLL,
destabilized an RNA-recognition domain that bound
with micromolar affinity to RNA containing the Ptprc
exon-silencing sequence. Hnrpll mutation selectively
diminished T cell accumulation in peripheral lymphoid
tissues but not proliferation. Exon-array analysis of
Hnrpll mutant naive and memory T cells revealed an
extensive program of alternative mRNA splicing in
memory T cells, coordinated by hnRNPLL. A remark-
able overlap with alternative splicing in neural tissues
may reflect a co-opted strategy for diversifying
memory T cells.
INTRODUCTION
Re-encounter with a foreign microbe or vaccine typically elicits
a recall immunological response that is heightened in speed and
magnitude. The simplest explanation for immunological memory
is clonal expansion of antigen-specific cells (Burnet, 1959).
Although most clonally expanded lymphocytes differentiate
exhaustively into effector cells or undergo apoptosis, a small
proportion persist for long periods after the immunological re-
sponse has ceased (Intlekofer et al., 2006; Stockinger et al.,
2006; Surh et al., 2006; Robertson et al., 2006; Williams and
Bevan, 2007). Immunological memory may equally depend
upon qualitative changes. ‘‘Memory’’ B cells are qualitatively
distinct because somaticmutations in their antigen-receptor var-
iable regions confer higher affinity (Neuberger et al., 2000), and
DNA rearrangements in their antibody constant-region gene
segments greatly enhance receptor signaling for plasma cellformation (Kaisho et al., 1997; Martin and Goodnow, 2002).
These somatic DNA-sequence changes are not a feature of
memory T cells, andmost studies ofmemory T cell differentiation
have focused instead on changes in transcription of cytokine-
and homing-receptor genes (Kaech et al., 2002; Ansel et al.,
2006; Intlekofer et al., 2006; Lee et al., 2006; Sallusto et al.,
2004; Stockinger et al., 2006; Szabo et al., 2003; Vinuesa
et al., 2005).
Memory Tcells appear not to revert to a naiveT cell state for the
most part, an observation made on the basis of studies involving
the most widely used marker for distinguishing naive T cells from
memory T cells inman andmany othermammals, CD45RO (Bev-
erley, 2004). CD45RO is a variant of the CD45 major leukocyte
transmembrane protein-tyrosine phosphatase, generated by
alternative mRNA splicing (Hermiston et al., 2003). Naive T cells
express distinct isoforms, typically CD45RB and CD45RAB or
CD45RBC,due to inclusion in theN-terminal extracellular domain
ofO-glycan-rich A, B, or C segments encoded in thePtprcmRNA
by exons 4, 5, and 6, respectively. Inmemory T cells, as well as in
recently activated T cells, exons 4–6 are silenced and excluded
from Ptprc mRNA, resulting in the CD45RO isoform detected
by specific monoclonal antibodies in man. Molecular biology
studies of T cell lines and human polymorphisms have delineated
a specific nucleotide sequencemotif in Ptprc exons 4, 5, and 6—
the activation-responsive sequence (ARS)—that is necessary
and sufficient for silencing these exons in activated and memory
T cells (Lynch andWeiss, 2000; Rothrock et al., 2003; Tong et al.,
2005). Both T cell fusion with B lymphocytes (Rothstein et al.,
1992), which do not silence these exons, and studies with
inhibitors of protein-synthesis and protein kinase C (PKC) signal-
ing (Konig et al., 1998; Lynch and Weiss, 2000) point to the
existence of an inducible exon-silencing protein specifically
expressed in T cells. Although regulated silencing of these exons
in T cells is highly conserved across species, the nature of the
trans-acting splicing factor(s) that reprogram CD45 splicing
remains obscure. Here, we have identified a gene that was
upregulated in memory T cells, encoded a protein with an RNA-
recognition domain that bound directly to the Ptprc ARS element
in vitro, and, in mice, played an essential, specific, and gene
dosage-dependent role in alternative splicing of Ptprc and many
other mRNAs differentiating memory T cells from their naive
counterparts.Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 863
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The thunder ENU Mouse Mutation Disrupts
Peripheral T Cell Subsets
Pedigrees of ethylnitrosourea (ENU)-mutagenizedC57BL/6mice
segregating thousands of random single-nucleotide substitu-
tions (Nelms andGoodnow, 2001) were screened by flow cytom-
etry for heritable mutations affecting the circulating proportions
of memory and naive T cells. Pedigree ENU126 segregated
a Mendelian recessive increase in the proportion of blood CD4+
and CD8+ cells with high CD44, a marker of activated and mem-
ory T cells (Figure 1A). Given the fewer overall CD4+ cells (see
below), the strain was named thunder for Th cells under normal.
Stainingwith antibodies to theRB isoformofCD45,which is pres-
ent on naiveCD4+ T cells but replacedby theCD45RO isoformon
Figure 1. ENUMouseMutation that Disrupts Accu-
mulation of Naive and Memory T Cells and Expres-
sion of CD45RO
Flow-cytometric analysis of cells fromWT +/+ (unfilled his-
tograms and symbols), thu/+ (gray) and thu/thu (filled
black) mice. This scheme of symbols and colors applies
to all panels.
(A) CD44 on CD4+ or CD8+ blood T cells. The percentage
of memory (CD44hi) and naive (CD44lo) subsets is shown.
(B) Staining for specific CD45 isoforms or an epitope com-
mon to all isoforms (CD45.2), gated on splenic CD4+ or
CD8+ T cells or B cells.
(C) Number of CD4+ or CD8+ SP T cells in the thymus at
6 weeks.
(D) Number of naive or memory CD4+ and CD8+ T cells in
the spleen at different ages.
(E) T cells in irradiated mice reconstituted with an equal
mixture of +/+ CD45.1 and thu/thu CD45.2 (CD45.1-nega-
tive) bone marrow. Control mixed chimeras were reconsti-
tuted +/+ CD45.1 and +/+ CD45.2 bone marrow. Left
panel shows percentage of CD4+ or CD8+ T cells that
are CD45.1-negative, representing thu/thu T cells in the
test mixed chimeras (filled squares) or +/+ T cells in the
control mixed chimeras (open circles). Right panel shows
percentage of CD4+ or CD8+ T cells that are CD45.1-pos-
itive, representing +/+ T cells either in the test mixed
chimeras (filled squares) or in the control chimeras (open
circles).
(F) Percentage of memory T cells among the CD45.1-
negative T cells in (E), representing thu/thu T cells (filled
squares) or +/+ T cells (open circles).
(G) A 50:50mixture of +/+ CD45.1 and thu/thuCD45.2 thy-
mocytes was injected into Rag1/ mice. The percentage
of T cells of each donor type is shown at the time of injec-
tion and in the blood at different times after transfer.
memory T cells, revealed no CD45RBlo T cells in
peripheral lymphoid tissues (Figure 1B). Staining
with antibodies to CD45RA and CD45RC iso-
forms, which are normally low on most CD4+
T cells and absent on memory T cells, showed
that these were highly expressed on all T cells
from the mutant strain (Figure 1B) and on den-
dritic cells, macrophages, and granulocytes
(Figure S1, available online). Homozygous
mutant mice were, nevertheless, born at the
expected Mendelian frequency and were indistinguishable
from WT (WT) littermates in appearance and behavior by visual
inspection.
The increased percentage of CD44hi T cells was secondary to
a loss of CD44lo naive T cells from peripheral lymphoid tissues.
Thymic T cell development and numbers of CD4+ and CD8+
single positive (SP) thymic T cells were indistinguishable from
the WT (Figure 1C). Peripheral CD4+ and CD8+ T cells were
also present in normal numbers in two-week-old mutant mice,
consistent with normal production and emigration from the
thymus, but the CD44lo subset failed to accumulate normally in
the peripheral blood, spleen, and lymph node as the animals ma-
tured (Figure 1D). Transplantation of thunder bone marrow dem-
onstrated that the mutation acted within T cells and not within
radioresistant stromal elements of lymphoid tissues (Figure S2A).864 Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc.
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irradiatedmicewith equal mixtures ofWT and thunder bonemar-
row, distinguished by allelic variants in the constant extracellular
segment of CD45: CD45.1 onWT andCD45.2 onmutant-derived
leukocytes. The mutation acted cell autonomously to decrease
accumulation of peripheral naive and memory T cells bearing
the thunder mutation (CD45.1 negative cells, Figures 1E and
1F) but had no effect on thymic T cell differentiation, even under
these competitive conditions (not shown). In contrast to animals
in which all T cells bear the mutation, in mixed chimeras there
was no increase in the percentage of CD44hi T cells among the
peripheral T cell subset bearing the mutation (Figure 1F). From
this result, we infer that CD44hi T cells compensate for peripheral
T cell lymphopenia by homeostatic proliferation in animals in
which all T cells bear the mutation, whereas in mixed chimeras,
compensation occurs through replacement by WT T cells.
The evidence that the thunder mutation acts within peripheral
T cells to diminish their persistence but not their proliferation
was extended by cell-transfer, cell-culture, and viral-challenge
experiments. Transfer of equal mixtures of WT and thu/thu
thymocytes, distinguished by CD45.1 and CD45.2 allotypes, re-
spectively, into Rag1/ or irradiated mice lacking peripheral
T cells showed that the mutant T cells (CD45.1-negative) selec-
tively failed to compete with WT T cells for repopulating the
recipient mice (Figure 1G). When the transferred cells were first
labeled with CFSE dye for measuring lymphopenia-induced
homeostatic cell division, thunder T cells nevertheless divided
indistinguishably from controls (Figure S2B). Similarly, thunder
T cells proliferated indistinguishably from WT T cells when stim-
ulated with antibodies to CD3 and CD28 in vitro (Figure S3A) and
differentiated into Th1 or Th17 effector cell subsets (Figure S3B).
Upon challenge with influenza virus, thundermice were capable
of generating large populations of nucleoprotein-specific CD8
cells (Figure S3C).
thunderMutation Cripples a Gene-Dosage-Sensitive
Silencer of Ptprc Exons
To understand the dramatic shift in CD45 isoforms expressed by
thunder T cells, we analyzed Ptprc mRNA splicing by RT-PCR
using primers spanning exons 3–7 (Figure 2A). WT thymocytes
predominantly carried PtprcmRNA lacking exons 4, 5, and 6 (en-
coding CD45R0) or containing only exon 5 (encoding CD45RB).
By contrast, a greater proportion ofPtprcmRNA in thu/thu thymo-
cytes contained exons 4, 5, and 6, encoding CD45 isoforms of
higher molecular weight. The relative use of exons 4, 5, and 6
was quantified by flow-cytometric staining with monoclonal anti-
bodies to the corresponding CD45RA, CD45RB, and CD45RC
segments (histograms,seeFigure1B;quantitation,seeFigure2B).
Thesewere 10–100 times higher on thu/thu thymic and peripheral
T cells than on WT counterparts and were comparable to the
amounts on B cells, which do not silence these exons, whereas
there was no difference in pan-CD45 staining intensity. In thu/+
heterozygotes, themutation caused an intermediate silencing de-
fect correlated with the number of ARS motifs in the correspond-
ing exons: in CD4+8+ double positive (DP) or CD4SP thymocytes,
thu/+ heterozygosity caused only a subtle defect in CD45RA si-
lencing (threemotifs), an intermediate defect inCD45RCsilencing
(twomotifs), andamarked failure to silenceCD45RB (singlemotif)
(Figure 2B). Thus, the thundermutation disrupts an essential andFigure 2. Thunder T Cells Fail to Silence Ptprc Exons 4–6
(A) Thymus cDNA from three different +/+ or thu/thumice, PCR amplified with
primers inPtprc exons 3 and 7. Specific RNA splice products were deduced on
the basis of their sequence-predicted sizes: RO, 71 bp; RB, 218 bp; RAB,
347 bp; RBC, 359 bp; RABC, 488 bp.
(B) Ptprc exon 4, 5, and 6 inclusion quantified in different cell subsets by geo-
metric-mean fluorescence staining with antibodies against the corresponding
CD45RA, CD45RB, and CD45RC segments. Relative CD45 expression was
measured in parallel with antibody to the CD45.2 epitope in amembrane-prox-
imal domain unaffected by alternative splicing. Abbreviations are as follows:
DN, CD48 double-negative thymocytes; DP, CD4+8+ double-positive
thymocytes; CD4 SP, CD4+ single-positive thymocytes; CD8 SP, CD8+
single-positive thymocytes; B, spleen B cells; CD4, spleen CD4 T cells;
CD8, spleen CD8 T cells. Data are from six animals of each genotype.
Columns indicate means, and error bars indicate standard deviations from
n = 6 mice.Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 865
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containing the ARS splicing-silencer motif.
Missense Mutation in a Memory T Cell-Induced
Gene, Hnrpll
The causative thunder mutation was identified by standard
meiotic mapping, sequencing, and gene complementation. The
thunder T cell abnormalities—both the failure to silence CD45
variable exons and the deficiency of naive T cells—mapped to
a single 2.1 Mb locus on distal chromosome 17, containing 21
transcription units (Figures 3A and 3B, Figure S4). This result ex-
cludes the possibility that mutations in genes outside this interval
account for the T cell abnormalities defined in Figure 1. All 21
transcripts within the interval were sequenced and compared
with parental B6 controls, but only Hnrpll contained a mutation:
an exonic T-to-A substitution resulting in a Val136-to-Asp codon
change (Figure 3C). The mutated valine was in the first of three
RNA recognition motif (RRM) domains in the hnRNPLL protein
(Figure 3D) and was absolutely conserved in vertebrates and in
similar domains of other hnRNPs (Figure 3E). Strikingly, the most
closely related protein, hnRNPL (Hnrpl), has previously been
shown to bind the Ptprc ARS motif (Rothrock et al., 2005; Tong
et al., 2005). We confirmed that the Hnrpllmutation was respon-
sible for the thunder splicing defect by restoring CD45RC silenc-
ing in thu/thu T cells transduced withWTHnrpll cDNA expressed
in a bicistronic retroviral vector (Figure 3F).
The data above established that hnRNPLL is an essential
trans-acting factor for silencing Ptprc exons in vivo but did not
explain how silencing is developmentally regulated between
naive andmemory T cells. Measurement ofHnrpllmRNA in naive
and memory T cells by real-time PCR or by microarray showed
that it was increased 300% in memory T cells, whereas Hnpl
was not (Figure 3G and Figure S5A). B cells expressed much
lower HnrpllmRNA than did T cells (Figures S5B and S5E), con-
sistent with the absence of a Ptprc exon-silencing factor in B
cells (Rothstein et al., 1992). Analysis of GEO-deposited micro-
array data showed that Hnrpll mRNA was induced 400% by
T cell receptor (TCR) stimulation through PKC-dependent signal-
ing (Figure S5C; Safford et al., 2005), consistent with the charac-
teristics for ARS-dependent silencing (Lynch and Weiss, 2000).
Foxp3+CD25+ T cells are also CD45RBlo and had elevatedHnrpll
mRNA compared to CD4+25 T cells (Figure S5D; Fontenot
et al., 2005). Given the marked effects on CD45 silencing when
the WT Hnrpll gene dose was halved (Figure 2B), increased
expression of Hnrpll is sufficient for explaining the regulated
silencing of CD45 in memory T cells.thunder Mutation Destabilizes an ARS
RNA-Binding Domain
Structural and binding studies were carried out for understand-
ing how the mutation affected the RRM1 domain of hnRNPLL
(Figure 4). The domain adopted the canonical RRM fold (Maris
et al., 2005) andwas structurally very similar to the RRM1domain
of PTB1 (Simpson et al., 2004), with which it shared 52%
sequence similarity and an average pairwise backbone rmsd of
1.9A˚ (Figure S6G). The V136 side chain was buried, suggesting
that the V136D mutation could disrupt the structure of the do-
main. Comparison of NMR spectra of bacterially expressed WT
and mutant hnRNPLL RRM1 domains (Figures S6A and S6B) re-
vealed that the spectral changes caused by the V136D mutation
were limited to the vicinity of helix a1, which lay beneath the
b sheet surface containing the conserved residues responsible
for RNA binding in other RRM domains (Figures 4A and 4C;
Figure S7A).
Binding of the RRM1 domain to RNA containing the Ptprc ARS
motif was established byNMRspectroscopy (Figures 4Band 4D;
Figures S6 and S7), monitoring the titration of the RRM1 domain
with single-stranded 15-mer RNA comprising the potent ARS
exon-silencing sequence from Ptprc exon 6 region 7, defined
by Tong et al. (2005). Both NMR analysis (Figure 4E) and isother-
mal calorimetry (Figure 4G; Figure S8) yielded an affinity of the
WT hnRNPLL RRM1 domain for ARS RNA of 1–2 mM at 25C
and 15C. This value is comparable to the RNA affinity of other
isolated RRM domains (Maris et al., 2005). In particular, 1–3 mM
affinity for oligonucleotides has been reported for the isolated
RRM1 and RRM2 domains of PTB1, which are closely related
to the RRM1 domain of hnRNPLL. Cooperativity among the four
RRMs in the PTB1 protein leads to nM affinity for RNA (Auweter
et al., 2007), and a similar mechanism may operate among the
three RRM domains to enhance the binding affinity of full-length
hnRNPLL.
The NMR data showed that RNA interacts selectively with
conserved RNA contact residues, such as His128 and Gln162,
across the b1 and b3 sheet surface defined previously as the
RNA binding site for PTB1 and other RRM domains (Maris et al.,
2005).Weconfirmed specificity of binding byprobing the interac-
tion of the WT RRM1 domain with a mutant RNA oligonucleotide
bearing two substitutions, from GCACGCA to GGACGUA, that
are sufficient to inactivate exon 6 silencing activity in cells
(Tong et al., 2005). The RNA sequence changes greatly reduced
the number of shifted peaks in theNMRspectrumand thebinding
affinity, as expected for nonspecific binding (Figure S6E). Thus,
thehnRNPLLRRM1domainbindsRNAwith sequence specificityFigure 3. thunder Is a Missense Mutation in the RNA-Recognition Motif of hnRNPLL
(A) Meiotic mapping of thunder to a 2.1 Mb interval derived from the B6-thunder strain.
(B) Candidate RNA-regulating genes within the interval.
(C) T/A substitution in thunder mRNA nucleotide 684, codon 136.
(D) Predicted domains of the hnRNPLL and hnRNPL proteins. Abbreviations are as follows: RRM, RNA recognition motif domain; PR, proline rich domain.
(E) Amino acid sequence alignment of the hnRNPLL RRM1 domain from different vertebrate species and with corresponding RRM domains from hnRNPL and
PTB1. Gold boxes denote two RNPmotifs that form a central binding site for RNA, with key RNA contacts on H and Q residues. The regular secondary-structure
elements in the RRM1 domain of hnRNPLL are indicated at the top.
(F) thu/thu T lymphoblasts were transduced with a bicistronic retroviral vector containing WT Hnrpll cDNA and EGFP or containing WT EGFP alone. Flow-cyto-
metric staining for CD45RC is shown gated on GFP+ cells (gray histograms) compared with nontransduced GFP cells in the same culture (open histograms),
showing correction of CD45RC silencing by the WT cDNA.
(G) RelativemRNA abundance ofHnrpll (upper panel) andHnrpl (lower panel) inWT naive andmemory CD4+ andCD8+ T cells measured by qRT-PCR, normalized
to Ube2D1. Columns indicate means, and error bars indicate standard deviations from n = 3 mice.Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 867
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Tong et al. (2005).
The affinity of RRM1 forWTARSRNAwas barely altered by the
thundermutation (Figures 4F and 4H), consistent with conforma-
tional changes far from theRNA-binding surface. However, when
stabilities were assessed by differential scanning calorimetry
(DSC), themutation resulted in amuch lowermelting temperature
and a significant degree of unfolding above 25C, whereas the
structure of the WT domain was stable until at least 45C (Fig-
ure 4I). We infer from the combined NMR and DSC data that
Figure 4. hnRNPLL RRM1 Domain Struc-
ture, ARS RNA Binding, and Consequences
of the thunder V136D Mutation
(A) Ribbon representation of the hnRNPLL RRM1
domain (residues 124–202), including side chains
at the site of mutation (V136, yellow) and RNA con-
tact residues conserved in other RRM domains
(His128, Gln162). Red spheres: backbone amides
broadened beyond detection in the NMR spectra
of the V136D mutant. Orange spheres: backbone
amides for which the mutation results in different
chemical shifts.
(B) Same as (A) except that spheres identify back-
bone amides with different chemical shifts in the
presence of the 15-mer RNA 50-CCUUACCUGC
ACGCA-30, with red colors indicating amide pro-
tons broadened beyond detection in the presence
of the 15-mer RNA.
(C and D) Same as (A) and (B), but with ribbon
representation of the PTB1 RRM1 domain (PDB:
1SJQ).
(E) Binding affinity of RRM1 domain to 15-mer
RNA, measured by NMR spectroscopy at 25C.
Kd values obtained from the chemical-shift
changes of His128, Asn169 and Ala192 were 0.1 ±
0.5 mM, 0.7 ± 0.7 mM, and 1.5 ± 1.3 mM, respec-
tively, indicating an upper limit of about 1.5 mM.
(F) Same as (E), but for V136D mutant. Corre-
sponding Kd values were 1.1 ± 0.4 mM, 1.0 ±
0.4 mM, and 2.0 ± 0.7 mM, indicating an upper limit
of about 2 mM.
(G) Binding affinity measured by isothermal calo-
rimetry at 15C. The continuous line represents
the least-squares fit of the data, yielding aKd value
of 1.9 ± 0.4 mM.
(H) Same as (G), but for the V136D mutant. The
fitted Kd value is 3.1 ± 1.4 mM.
(I) DSC curves of mutant (red) or WT (black) RRM1
domains. Both proteins precipitated irreversibly at
high temperature.
the V136D mutation interferes with ARS
RNA binding indirectly by producing a
thermolabile structure that is mostly
unfolded at 37C.
Hnrpll Controls Reprogramming
of Alternative Splicing in Memory
T Cells
We then asked whether splicing of other
genes was also dependent upon Hnrpll.
RNA was prepared from flow-sorted
spleen memory CD4 and memory CD8 cells, their naive CD44lo
counterparts, and CD4+ and CD8+ SP thymocytes. Four pools
of each cell typewere prepared frommore than four independent
thu/thu and +/+ mice, and mRNA was converted to labeled
cRNA and hybridized to Affymetrix Mouse Exon 1.0 ST Arrays.
The complete data set comprised 24 biologically independent
samples of mutant T cell RNA and 24 independent samples of
WT T cell RNA, thereby providing a high degree of replication.
These data have been deposited in the GEO database, and
a web-enabled interface for reviewing the exon data has been868 Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc.
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Data for 15,788 informative genes was first analyzed for changes
in discrete exons between thu/thu and +/+ cells within each T cell
subset by two-way (genotype 3 probe set) ANOVA. ANOVA
values of p = 0.001 and p = 0.05 were calculated as having false
discovery rates (FDRs) of 0.012–0.059 and 0.189–0.463, respec-
tively, in individual T cell types (Table S1). Each gene was then
ranked for reproducibility of two-way ANOVA evidence for al-
tered splicing in thu/thu cells across the six T cell subsets. Ptprc
ranked sixth overall, with an ANOVA p < 0.001 in five of the six
T cell subsets, thereby validating the analysis. For distiguishing
true alternative-splicing events from artifacts arising from unre-
sponsive or crosshybridizing probes or confounding effects of
changes in gene expression overall, the data for each high-
ranked gene was manually inspected by plotting of the mean
signal and standard error for each probe set and cell type in
alignment with annotated mouse exons and UCSC reference
transcripts (Figure 5). Of the 35 probe sets forPtprc exons, probe
set signals for exons 4, 5, and 6 were selectively elevated in thu/
thu compared to +/+ for all six T cell subsets, providing striking
validation of the exon-array data and our analysis approach
(Figure 5A).
The validated analysis strategy outlined above was then ap-
plied to the full data set. We found that 343 genes exhibited a
genotype3 probe set ANOVA p < 0.05 in four or more cell types.
Data for the 228 most highly ranked genes were manually re-
viewed against UCSC mouse reference transcripts (representa-
tive examples, see Figures 5B–5H; all annotations, see Figures
S9–S14 and Tables S2–S7), placing them into one of six cate-
gories. Categories A–D comprised 125 genes with probe sets
that reproducibly changed inHnrpllmutant T cells corresponding
to internal exons in UCSC reference mousemRNAs (listed in Fig-
ure 6). Of these, 59 genes (47%) had Hnrpll-dependent probe
sets corresponding to alternatively spliced exons already identi-
fied in UCSC reference transcripts. The fact that such a high pro-
portion correspond to sequence-validated alternative-splicing
events represents further validation of the exon-array data and
analysis, because the current set of reference mRNAs appear
to cover less than half of the alternative splice events (Blencowe,
2006;Clark et al., 2007; Einstein et al., 2008; Yeo et al., 2007). The
59 transcript-validated geneswere subdivided intoGroupsA and
B. Group A comprised 27 genes, including Ptprc, in which the
signal increased in thu/thu cells, indicating a failure of exon
silencing in the mutant T cells. In group B (32 genes), the signal
decreased in thunder T cells, implying decreased exon inclusion
resulting fromHnrpll deficiency. GroupC (42 genes) andGroupD
(24 genes) mirrored Groups A and B, respectively, except that
the Hnrpll-dependent probe sets were not currently identified
as an alternatively spliced exon by a reference mouse mRNA.
Genes with Hnrpll-dependent probe sets corresponding to the
first exon of UCSC reference transcripts were assigned to Group
E (64 genes). These potentially represent alternative promoters
and mRNA start sites, and this was clearly the case for a number
that were manually compared to transcript, EST, and published
evidence (Figure S13 and Table S6). Genes assigned to
Group F (38 genes) exhibited complex patterns of changes in
Hnrpll-dependent probe sets, such as changes in overall mRNA
expression from single-transcript or multiple-transcript gene
complexes.Additional manual analysis was performed for the 59 tran-
script-validated Hnrpll-dependent genes in Groups A and B.
First, the probe set and transcript-gene views were manually
compared to all mouse transcripts, mouse ESTs, and transcripts
of other species in the UCSC Genome Browser (July 2007 as-
sembly) for detection of conserved alternative-splicing events
in man and other species. Second, published information on
alternative splicing for these 59 genes was identified by a search
of the gene symbols and names of the encoded proteins in NCBI
Homologene, OMIM, and PubMed databases and then a reading
of the abstracts and papers for the identification of information
about alternative splicing. Two important points emerged. First,
theHnrpll-regulated alternative-splicing events identified in 63%
of genes in Group A and 38% in Group B were conserved be-
tween mouse and man, ascertained on the basis of sequenced
mRNA variants in the two species (asterisks in Figure 6). This
level of human-mouse conservation provided additional valida-
tion of the Hnrpll-dependent splicing events identified by the
array analysis, because only 10%–20% of alternatively spliced
exons appear to be conserved between man and mouse overall
(Blencowe, 2006).
Many of the evolutionarily conserved, Hnrpll-dependent alter-
natively spliced forms alter the encoded proteins in important
ways. For example, thu/thu T cells had a marked increase in
mRNA signal selectively for alternatively spliced Kif21a exons
encoding part of the cargo-binding segment of this microtubular
transport kinesin (Figure 5B), which may alter polarized interac-
tions with antigen-presenting cells. The thu-diminished signal
for Map3k7 exon 12a (Figure 5C) encodes a 27 aa insert in the
carboxy-terminal interaction domain of TGF-b-activated kinase
1 (TAK1), a key enzyme for inflammatory signaling to NF-kB
(Kondo et al., 1998; Sakurai et al., 1998).Pax6 exon 5a (Figure 5D)
encodes a conserved insert within the DNA-binding paired
domain that alters the specificity of this transcriptional regulator
of neuronal cell development (Dominguez et al., 2003). In thunder
T cells, there was increased expression of a spliced form ofNlrp1
mRNA (Figure 5E) encoding a shorter form of the NALP1 inflam-
masome sensor for bacterial muramyl dipeptide, lacking two of
the leucine rich repeats and other segments between the cas-
pase recruitment domain and the nucleotide binding domains
(Bruey et al., 2007; Hlaing et al., 2001). The multiple alternatively
spliced exons in Tle1 (also called Grg1; Figure 5F) encode gly-
cine-proline rich (GP) and leucine zipper (LZ) protein-interaction
domains and an alternative stop codon and 30UTR that are
variably excluded from the long forms and delta GP or delta LZ
forms of this transcriptional repressor (Lepourcelet and Shivda-
sani, 2002).
The second finding frommanual analysis was that for 15 of the
27 genes (56%) in Group A, the exons showing Hnrpll-depen-
dent alternative splicing have been published as undergoing
alternative splicing in the nervous system (chevrons in Figure 6,
details in Supplemental Data). This remarkable overlap could re-
flect a shared strategy for cellular diversification, consistent with
the observation that alternative splicing appears to be more
common in genes expressed in functionally complex tissues
with diverse cell types, such as the brain and the immune system
(Blencowe, 2006). Indeed,many of the alternative-splicing events
regulated by Hnrpll in T cells have important functions in the
nervous system (see Supplemental Data). For example, theImmunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 869
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Memory T Cell RNA SplicingHnrpll-dependent exons in Kif21a (Figure 5B) are also alterna-
tively spliced in neurons and this gene is mutated in congenital
fibrosis of the extraocular muscles, types 1 and 3 (CFEOM; Ya-
mada et al., 2003). The internal exons of Itsn1 that are enhanced
in thu/thu T cells, as well as the short mRNA form enhanced in
memory T cells (Figure 5G), encode different isoforms of Inter-
sectin 1, a multidomain protein functioning in clathrin-mediated
endocytosis, which through variable silencing of 30 splice donors
produces a neuronal-specific long form and two shorter forms
(Tsyba et al., 2004). The enhanced alternative Grip1 exon in
thunder cells (Figure S9) encodes a palmitoylated, membrane-
associated Grip1b form of Glutamate Receptor Interacting Pro-
tein 1, a multi-PDZ-domain intracellular scaffolding protein that
plays a key role in cell-matrix interactions during development,
neuronal dendrite morphogenesis, and synaptic reorganization
of AMPA receptors (Charych et al., 2006). Although thundermu-
tant mice display no abnormalities in gross behavioral or motor
skills, these observations, coupled with the wide expression of
Hnrpll in the brain (Figure S5E), make it logical for future studies
to test thunder mutant animals for specific neural defects.
In parallel, we queried the array data for alternative splicing
occurring in WT T cells between naive andmemory subsets (Fig-
ure 6). This revealed 2873 genes (18%) with two-way ANOVA
evidence at p < 0.05 (FDR 0.607–0.693) for alternative splicing
between naive and memory CD4 or CD8 cells. We found that
1725 genes (10.9%) exhibited ANOVA p < 0.001 (FDR 0.026–
0.036) in either CD4 or CD8 memory cells, with 565 (3.6%) scor-
ing p < 0.001 in both memory cell types (Table S7). Genes with
altered splicing in thunder T cells were significantly enriched
for genes with evidence of altered splicing between WT naive
and memory cells: 96 of the 228 most highly ranked Hnrpll-
dependent genes (42%) also had evidence (p < 0.05) for altered
splicing in normal memory cell differentiation, contrasting with
18% expected by chance (chi-square test, p < 0.0001). Manual
inspection of the probe set data showed the congruence be-
tween Hnrpll dependency and altered splicing in WT memory
T cell differentiation also applied at the level of the individual
probe sets and exons (Figures S9–S14).
DISCUSSION
The findings above revealedHnrpll to be a regulated gene in lym-
phocytes,most highly expressed in CD45ROmemory T cells and
Treg cells that fully silence the Ptprc variable exons, expressed
at lower amounts in naive T cells that fail to silence exon 5 encod-
ing CD45RB, and expressed at the lowest amounts in B cells that
do not silence any of these exons and express CD45RABC.Genetic and structural studies delineated a critical RRM1 do-
main in the hnRNPLL protein that bound RNA containing the
consensus ARS exon-silencing sequence but not a mutant
ARS sequence lacking exon-silencing activity. A point mutation
that destabilized the RRM1 domain inactivated silencing of all
three exons when homozygous, and in the heterozygous state,
the mutation partially compromised silencing in concordance
with the known relative strength of the ARS sequence in each
exon. The hnRNPLL protein thus fulfils the criteria for the induc-
ible silencing factor in T cells and explains the regulated changes
in CD45 splicing that serve as a key marker for memory T cells in
many species.
Oberdoerffer et al. (2008) recently performed a complementary
study using an shRNA screen of potential splicing factors in
human Jurkat T lymphoma cells to find that hnRNPLL is essential
for silencing CD45 exons 4, 5, and 6. The fact that two different
screens identify the same gene and protein underscores the
specific requirement for hnRNPLL inCD45exonsilencing.Never-
theless, the two studies differ in their conclusions about the
global function of hnRNPLL in T cells. Oberdoerffer et al. observe
that during puromycin selection for a vector encoding an shRNA
against hnRNPLL, human T lymphoblasts expressing this vector
proliferate poorly compared to those expressing a control vector.
This result contrasts with the identical proliferation of hnRNPLL
mutant andWTTcells observed here. Oberdoerffer et al. suggest
other targets of hnRNPLL by exon-array analysis, but the study
does not appear to employ biological replicates or cell sorting
of matched subsets to control for the confounding effect of re-
duced proliferation in cells expressing Hnrpll shRNA. Few genes
listed by Oberdoerffer et al. correspond to Hnrpll-dependent
alternative-splicing events identified in the 48 independent
samples of sorted T cells analyzed here. In particular, STAT5
and CD44 exhibit alternative splicing in T lymphoblasts express-
ing hnRNPLL shRNA, whereas we found no evidence for this in
any subset of hnRNPLL mutant T cells (Figure S15). Because
STAT5, CD44, and IL2RA are correlated with T cell proliferation,
the differences described by Oberdoerffer may be secondary to
reduced proliferation of the shRNA-expressing cells compared
to the controls. Nevertheless, it is also possible that the discrep-
ant findings reflect differencesbetweenmouseandhumanTcells
or between knockdown of hnRNPLL compared to point mutation
of the RRM1 domain.
A key finding from our study is that changes in Ptprc splicing
represent the tip of a large network of alternative splicing in
memory T cells—with hundreds of other genes undergoing
Hnrpll-dependent splicing. The set of genes identified here thus
provides a unique resource for discovering new markers andFigure 5. Exon-Array Probe-Set Data According to Hnrpll Genotype and T Cell Subset, Aligned with Corresponding Exons and Reference
Transcripts
Log2mean and standard error of the signal for each probe set is shown for either CD4+ or CD8+ T cells (memory thu/thu in red, memory +/+ in green, naive thu/thu
in blue, naive +/+ in purple), normalized against the mean signal on the same probe set in corresponding naive +/+ cells. Grey arrows indicate sites of transcript
initiation.
(A and B) Examples of genes in Group A, in which signal is consistently increased in thu/thu cells for probe sets corresponding to known alternatively spliced
internal exons.
(C and D) Examples of genes in Group B, in which signal is consistently decreased in thu/thu cells for probe sets corresponding to known alternatively spliced
internal exons.
(E and F) Examples of genes in whichmultiple internal but noncontiguous exons, corresponding to known transcript isoforms, show consistentHnrpll-dependent
changes.
(G and H) Examples of genes in which variable silencing of an internal splice donor creates alternative 30 mRNA and carboxy termini.Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 871
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genes exhibited failure of exon silencing like Ptprc (Groups A
and C), an equal number showed the opposite effect (Groups B
and C). hnRNPLL may act directly as an exon-splicing enhancer
in the latter instances, consistent with evidence for other hnRNPs
(Hung et al., 2008). Alternatively, hnRNPLL may promote exon
inclusion indirectly by affecting splicing-enhancer factors. It is
indeed likely that the direct effects of hnRNPLL are amplified by
a cascade of secondary changes, given that alternative splicing
in thunder T cells affected a number of RNA-processing regula-
tors, including Smn1, Cpsf4, Prpf4b, Ccnl2, Thrap3, and Sfrs11.
There were also many instances of genes (Group E) with Hnrpll-
dependent changes in the relative use of alternative first exons
and apparent mRNA start sites. This, again, may reflect a cas-
cade, given that many thunder-altered genes encode transcrip-
tional regulators, including Arid3b, Smarca, Nfatc1, Mlx, Foxd1,
Tle1, Grg1, Tcf7l2, and Pax6.
The intrinsic failure of Hnrpll mutant T cells to persist in the
periphery may reflect altered splicing of many genes controlling
cell signaling and survival among theHnrpll-regulated set. These
include regulators of apoptosis Nlrp1 (encoding NALP1), Lrdd
(encoding PIDD), Madd (encoding DENN), Apaf1, Cyc1 (encod-
ing Cytochrome-c), and Bcl2l11 (encoding Bim). Multiple com-
ponents of the TCR and other receptor signaling pathways are
alternatively spliced by Hnrpll, including Ptprc, other transmem-
brane protein tyrosine phosphatases Ptprt and Ptprk; kinases
Figure 6. hnRNPLL Controls Alternative Splicing of Numerous mRNAs
Summary of exon-array analysis of mRNA from naive and memory CD4+ and CD8+ T cells and SP thymocytes sorted from thu/thu and +/+ mice (four biological
replicates of each cell and genotype). Of the 228 most highly ranked Hnrpll-regulated genes, those assigned to Group A (red font) and Group B (blue font) con-
tainedHnrpll-dependent probe sets corresponding to known alternatively spliced exons in referencemouse transcripts. Asterisks denote genes with transcript or
published data for alternative splicing of the same exons in man. Chevrons denote genes with published data for alternative splicing of the same exons in neural
tissue. Groups A and C (green font): genes with Hnrpll-dependent exons exhibiting consistently increased signal in thu/thu. Groups B and D (purple font): genes
with Hnrpll-dependent exons exhibiting consistently decreased signal in thu/thu. Black font denotes genes in Group E, with Hnrpll-dependent probe sets that
appear to reflect alternative promoter use, and in Group F, with a complex pattern of changes in Hnrpll-dependent probe sets.872 Immunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc.
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Memory T Cell RNA SplicingMap3k7 (TAK1), Rps6kb2 (S6-kinase), Pctk1, and Abelson tyro-
sine kinase; the TCR CD3-zeta subunit Cd247; phospholipase
c gamma 1 Plcg1; adaptors Dok2, Sorbs2, Fam48a; and regula-
tors of posttranslational modification by ubiquitin, NEDD8, and
ISG15: Ube1l, Ufc1, and Fbxw2. Other Hnrpll-dependent genes
are involved in the intracellular calcium response (Cadps2,
Kcnip2, Ankra2, Otof, and NFATc1), cell adhesion and cytoskel-
etal reorganization (Grip1, Cobl, Sorbs2, Spnb2, Fermt3, Mtap4,
Myo7a, and Nisch), or vesicle and intracellular transport and
targeting (Kif21a, Mtap4, Grip1, Itsn1, Dync1i1, Tpd52l1, Pctk1,
Osbpl1a, Nphp4, Myo7a, and Nisch). The shortened longevity
of T cells when Hnrpll function is crippled in thu/thu animals is
likely to reflect an accumulation of changes, rather than simply
being ascribed to an individual hnRNPLL target, such as Ptprc.
A similar conclusion has been reached for the shortened lifespan
of neurons brought about by mutations in the splicing regulator
Smn1 (Zhang et al., 2008), the splicing of which is itself regulated
by Hnrpll.
It is remarkable that more than half of the genes with known in-
ternal alternatively spliced exons that are found here to be
silenced by hnRNPLL (Group A) are well known as a result of
studies of alternative splicing in the brain and other neural tis-
sues. Like the immune system, the nervous system must adapt
to ever-changing environmental stimuli, and to do this, it must
generate an enormous diversity of cell types and plasticity of
firing patterns within these cell types (Muotri and Gage, 2006).
Unlike B lymphocytes, in which DNA rearrangement and muta-
tion play a central role in diversifying memory B cells from their
naive precursors for adaptaion to new environmental agents,
neuronal differentiation and memory does not appear to involve
DNA recombination ormutation. Instead, RNA rearrangement by
alternative splicing has emerged as a major element of neuronal
differentiation, diversity, plasticity, and memory (Li et al., 2007;
Muotri and Gage, 2006; Ule and Darnell, 2006; Zipursky et al.,
2006). The extensive RNA rearrangements revealed here in
memory T cells, as well as their overlap with neuronal alternative
splicing, suggests that memory T cells diversify their synapse
formation and response patterns by co-opting solutions evolved
originally for the brain.
EXPERIMENTAL PROCEDURES
Mice and Flow Cytometry
C57BL/6 male mice were mutagenized with four i.p. injections of 85 mg/kg
ENU, each 1 week apart (Nelms and Goodnow, 2001). All animal procedures
were approved by the Australian National University Animal Experimentation
Ethics Committee. Antibody conjugates were from BD PharMingen or Caltag.
For CFSE labeling, 5.03 107 cells/ml in RPMI 1640 were incubated for 10 min
at 37Cwith 5 mMCFSE (Molecular Probes) andwashed three times in ice-cold
RPMI/10% FCS. Data were acquired on a FACS Calibur and analyzed with
FlowJo software. For cell transfers, thymocytes from WT CD45.1 and thu/
thu (CD45.2) mice were mixed at a 50:50 ratio and CFSE labeled, and 2 3
107 cells were injected into the tail vein of RAG.1/ or irradiated C57BL6J
mice.
Mapping, cDNA Amplification, and Retroviral Complementation
DNA from (B6 3 CBA/H)F2 mice was analyzed by PCR for single-sequence-
length-polymorphism and single-nucleotide-polymorphism markers. cDNA
from +/+ and thu/thu spleens was PCR amplified and sequenced with primers
complementary for each Ensembl transcript in the linked interval. For retroviral
complementation, hnRNPLL cDNA was subcloned into the polylinker of bicis-tronic MSCV-IRES-EGFP vector, retrovirus-containing supernatant collected
from transfected Phoenix cells, spinoculated into magnetic-bead-enriched
splenic CD4+ T cells that had been activated with anti-CD3 and anti-CD28
for 24 hr, and analyzed by FACS 24 hr after spinoculation. CD45 exon 3–7
cDNA was amplified with 10 uM each of 50-GGCAAACACCTACACCCA-30
and 50-GCTTGCAAGGCCCAGAGTGGATGGTGTAAG-30 with the Elongase
polymerase kit (Invitrogen). Products were electrophoresed in 1.5% agarose
gel, stained with EtBr, and imaged with GeneSnap software.
Exon-Array Analysis
CD4-, CD8-, and CD44-stained spleen and lymph-node cells or thymocytes
were sorted into ice-cold RPMI 10% FCS on a FACS Vantage DIVA or FACS
Aria (Becton Dickinson). For each of the six cell types, multiple independent
+/+ or thu/thu donor mice were used for isolating four independent replicate
pools ofmRNA. For each pool, total RNAwas extracted from 2–5million sorted
cells with the RNeasy Plus Mini Kit (QIAGEN), purity was analyzed with an Agi-
lent Bioanalyzer Chip, 1 ug RNAwas in vitro transcribed to cRNA, and after the
first round of amplification, 10 ug cRNA was used in a second round of ampli-
fication. A hybridization cocktail that included 5.5 ug fragmented end-labeled
ssDNA was applied to Affymetrix GeneChip Mouse Exon 1.0 ST Array chips.
Hybridization was performed with F450-001 fluidics wash and stain script
with the use of the Affymetrics Gene Chip Fluidics Station 450. Arrays were
scanned with the Affymetrix GCS3000 7G and Gene Chip operating software
for the production of CEL files. Array data were deposited in NCBI’s Gene
Expression Omnibus (GEO) database (see Accession Numbers section).
Probe-set intensities were calculated from the CEL files of the 48 samples in
Partek Genomics Suite 6.3 with the use of the core probe sets defined by
Affymetrix. We included 15,788 informative genes in the analysis, defining an
informative gene with a unique transcript ID, with mean signals for individual
probe sets greater than 3 in the T cell samples analyzed. Alternative splicing
was analyzed by two-way (genotype 3 probe-set ID) ANOVA with the use of
Partek algorithms with no normalization. FDRs for the two-way ANOVA com-
parison of each T cell subset were calculated by the Benjamini and Hochberg
step-up method in Partek. Gene views were created with Partek, with the
use of known transcripts in the UCSC Mouse Genome database (July 2007
version).
RRM1-Protein Production
RRM1 domains were PCR amplified from plasmids carrying WT and thunder
Hnrpll cDNA and cloned into pETMCS III for the encoding of constructs of
111 residues including an N-terminal His tag. Residues 15–106 were ident-
ical to residues 7–98 in the NMR structure 1WEX. Residues 1–14 were
MHHHHHHMLSTEGG, and residues 107–112 were TDDPSG. The proteins
were expressed in E. coli BL21(DE3) by induction with 1 mM IPTG and purified
by Ni-NTA affinity chromatography (QIAGEN) with a step gradient of imidazole
(25–500 mM) used for elution. 15N/13C double-labeled samples of both pro-
teins were produced in M9 medium containing 1 g/l of 15NH4Cl and 4 g/l of
13C-glucose.
NMR Measurements and Fold Determination
We recorded NMR spectra of 0.8 mM (WT) and 0.4 mM (mutant) solutions
in NMR buffer (90% H2O/10% D2O, 50 mM Tris$HCl [pH 7.2], 50 mM NaCl,
1 mM NaN3, 3 mM DTT). All data were acquired at 25
C, with Bruker Avance
800 or 600 MHz NMR spectrometers equipped with cryoprobes. The reso-
nance assignments of theWT domain were performedwith HNCA, HN(CO)CA,
HNCACB, CBCA(CO)NH, HNHA, NOESY-15N-HSQC, H(C)CH-TOCSY, and
(H)CCH-TOCSY spectra, supplemented by recorded 15N-HSQC spectra of
five samples produced cell free with combinatorial 15N-labeling (Wu et al.,
2006). The 15N-HSQC spectrum of the mutant was assigned by a
NOESY-15N-HSQC spectrum and comparison to the assignments of the WT
protein. Interactions with RNA were probed by titration of a 67.5 mM solution
of 15N-labeled WT RRM1 domain in NMR buffer with a 1.5 mM solution of
the WT oligonucleotide 50-CCUUACCUGCACGCA-30 or the mutant 50-CCUU
ACCUGGACGUA-30 (Biospring, Germany) and monitoring of the chemical-
shift changes of the protein by 15N-HSQC spectra. The NMR resonance
assignments have been deposited at the Biological Magnetic Resonance
Bank (BMRB) (see Accession Numbers). The chemical shifts of the Ca, Cb,
C0, HN, Ha, and N spins were used for calculating the fold of the domainImmunity 29, 863–875, December 19, 2008 ª2008 Elsevier Inc. 873
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Memory T Cell RNA Splicing(residues 8–112, or 109-213 in the numbering of Figure 3E), with the use of CS-
Rosetta with the standard protocol of Shen et al. (2008) without rescoring of
the final structures. The lowest all-atom energy structure from 10,000 calcula-
tions (Figure S6F) is shown in Figures 4A and 4B. The coordinates can be
downloaded from http://rsc.anu.edu.au/go/coordinates and will be depos-
ited in the Protein Data Bank once the procedure for accepting Rosetta
outputs has been established.
Differential Scanning and Isothermal Calorimetry
Thermal stability was probed in NMR buffer with a differential scanning calo-
rimeter (VP-DSC, MicroCal). Thermograms were measured between 10C
and 62C for the WT RRM1 domain and between 10C and 45C for the
V136Dmutant, with a scan rate of 1.5C/min and protein concentrations below
200 mM. For isothermal calorimetry measurement of RNA binding, a 5 mM
solution of RRM1 domain was titrated with a 60 mM solution of RNA oligomer
and the heat absorbed per mole of titrant was monitored. Figures 4E and 4F
display the data obtained after subtraction of a control experiment, where
the RNA oligomer was titrated into buffer without protein (see Figure S8). A
constant of 0.6 kcal/mole (WT RRM1) or 2.5 kcal/mole (mutant RRM1) was
subtracted for elimination of a spurious sign change in the data after correction
by the data from the control titration into buffer.
ACCESSION NUMBERS
The GEO accession number for the microarray data reported in this paper is
GSE13416.
The BMRB accession number for the NMR resonance assignments is
15820.
SUPPLEMENTAL DATA
Supplemental Data include supplemental notes on group A neural spliced
genes, 15 figures, and eight tables and can be found with this paper online
at http://www.immunity.com/supplemental/S1074-7613(08)00508-6.
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